Articles tagged with “cancer-immunotherapy”

$AI Live Biotherapeutics for Refractory Oncology Explained$

AI Live Biotherapeutics for Refractory Oncology Explained

Review Kanvas Biosciences' AI live biotherapeutics for refractory oncology. Explore how spatial microbiome mapping and KAN-001 impact cancer immunotherapy.

40 min read

5/4/2026

ai biotherapeutics microbiome therapeutics refractory oncology cancer immunotherapy spatial microbiome mapping live biotherapeutic products immuno-oncology kanvas biosciences

Trispecific Antibody HH160: BeOne and Huahui Licensing Deal

Analyze the BeOne-Huahui licensing agreement for the HH160 PD-1/CTLA-4/VEGF trispecific antibody. Review recent China biotech cross-border licensing trends.

40 min read

4/25/2026

trispecific antibodies china biotech licensing hh160 beone medicines huahui health cancer immunotherapy cross-border licensing immuno-oncology